News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Kevin Smith (Cephalon)

Advertisement

is with Cephalon

Articles by Kevin Smith (Cephalon)

Implications and Opportunities of Applying QbD Principles to Analytical Measurement

ByKevin Smith (Cephalon),Matthias Pohl,Mark Schweitzer,Jaqueline Larew,Melissa Hanna-Brown,Gordon Hansen,Phil Nethercote,Phil Borman
February 1st 2010

The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods.

Advertisement

Latest Updated Articles

  • Implications and Opportunities of Applying QbD Principles to Analytical Measurement
    Implications and Opportunities of Applying QbD Principles to Analytical Measurement

    Published: February 1st 2010 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Why Investment Strategies Matter for Advancing Pharmaceutical Technologies

2

How AI, Machine Learning, and Large Language Models Enhance Bioanalysis

3

AAPS PharmSci 360 2025: Trends in Bioanalysis

4

PharmTech Weekly News Roundup – Week of November 3, 2025

5

AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us